• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

螺内酯与雌激素 - 孕激素疗法治疗多毛症。

Spironolactone and estrogen-progestin therapy for hirsutism.

作者信息

Board J A, Rosenberg S M, Smeltzer J S

出版信息

South Med J. 1987 Apr;80(4):483-6. doi: 10.1097/00007611-198704000-00019.

DOI:10.1097/00007611-198704000-00019
PMID:3563583
Abstract

Sixteen women with hirsutism used spironolactone, 100 mg daily without interruption, plus norethindrone (1 mg) and ethinyl estradiol (35 mg) for 21 of each 28 days. Clinical improvement occurred in 11 of the 16 patients and also in an additional patient when the dose of spironolactone was increased to 200 mg daily. Spironolactone 100 mg daily plus norethindrone and ethinyl estradiol resulted in significant reduction in serum total testosterone, serum free testosterone, and percentage of free testosterone. Side effects were infrequent.

摘要

16名多毛症女性连续每日服用100毫克螺内酯,同时每28天中有21天服用炔诺酮(1毫克)和炔雌醇(35毫克)。16名患者中有11名临床症状得到改善,另外1名患者在将螺内酯剂量增至每日200毫克时症状也有所改善。每日100毫克螺内酯联合炔诺酮和炔雌醇可使血清总睾酮、血清游离睾酮及游离睾酮百分比显著降低。副作用较少见。

相似文献

1
Spironolactone and estrogen-progestin therapy for hirsutism.螺内酯与雌激素 - 孕激素疗法治疗多毛症。
South Med J. 1987 Apr;80(4):483-6. doi: 10.1097/00007611-198704000-00019.
2
Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.多毛症:两种常用口服避孕药和螺内酯的代谢效应
Contraception. 1991 Aug;44(2):113-24. doi: 10.1016/0010-7824(91)90112-s.
3
Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans.
J Adolesc Health Care. 1987 Sep;8(5):445-8. doi: 10.1016/0197-0070(87)90235-x.
4
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.氟他胺与螺内酯加乙炔雌二醇/醋酸环丙孕酮治疗多毛症的临床疗效比较:一项随机对照研究。
Adv Ther. 2008 Apr;25(4):321-8. doi: 10.1007/s12325-008-0039-5.
5
High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Gynecol Endocrinol. 2004 Oct;19(4):190-5. doi: 10.1080/09513590400012069.
6
Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.螺内酯与口服避孕药联合使用:多毛症的一种替代治疗方法。
Br J Obstet Gynaecol. 1985 Sep;92(9):983-5. doi: 10.1111/j.1471-0528.1985.tb03081.x.
7
Therapeutic evaluation of spironolactone in Indian women with hirsutism.螺内酯对印度多毛症女性的治疗评估。
J Assoc Physicians India. 1986 Aug;34(8):577-9.
8
Hirsutism--a low dose spironolactone therapy.多毛症——低剂量螺内酯疗法
Acta Univ Palacki Olomuc Fac Med. 1989;122:239-45.
9
Low-dose spironolactone in the treatment of female hirsutism.低剂量螺内酯治疗女性多毛症
Int J Fertil. 1987 Jan-Feb;32(1):41-5.
10
Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Acta Med Okayama. 2003 Apr;57(2):73-6. doi: 10.18926/AMO/32820.

引用本文的文献

1
Polycystic Ovary Syndrome and Gender Identity.多囊卵巢综合征与性别认同。
Yale J Biol Med. 2020 Sep 30;93(4):529-537. eCollection 2020 Sep.
2
A risk-benefit assessment of pharmacological therapies for hirsutism.多毛症药物治疗的风险效益评估。
Drug Saf. 2001;24(4):267-76. doi: 10.2165/00002018-200124040-00004.